A skin cancer expert, Dr. Suephy Chen has been recognized by both the National Institutes of Health and the Veterans Administration for her outstanding work as a researcher and physician.
Titles and Roles
- Director, Dermatology Clinical and Outcomes Research Unit
- Winship Cancer Institute of Emory University
- Director, Cutaneous Melanoma and Pigmented Lesion Clinics
- WInship Cancer Institute of Emory University
- Associate Professor and Vice Chair, Department of Dermatology
- Emory University School of Medicine
- Director, TeleDermatology Services
- Atlanta VA Medical Center
- Research Program
- Cancer Prevention and Control
Suephy Chen, MD, MS, began practicing at Emory Healthcare in 2000 and has been board certified in dermatology since 1997. In addition to melanoma, Dr. Chen has clinical interests in pruritus, psoriasis, and atopic dermatitis.
Dr. Chen is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University. She is also a member of the American Academy of Dermatology, the Society for Investigative Dermatology, and the Women's Dermatology Society. In addition, she is a founding member of the Pigmented Lesion Group of the Melanoma Prevention Working Group.
Dr. Chen earned her Doctor of Medicine from Johns Hopkins University School of Medicine. She completed her internship at the Beth Israel Hospital, a Harvard University teaching hospital, before continuing on to a dermatology residency at Emory University Hospital. She obtained her Master of Science in Health Services Research at Stanford University and completed her fellowship at Stanford Hospital.
Dr. Chen is the recipient of many honors including the K23 Career Development Award from the National Institutes of Health, the Dermatology Foundation Health Care Policy Clinical Career Development Award, Merit Review Award from the Veterans Administration, and the National Research Service Award from the Agency for Health Care Policy and Research, among others.
Dr. Chen is interested in quantifying the burden of skin disease, particularly the quality of life and economic burden on both patients and society as a whole. She is also interested in testing new technologies in the delivery of dermatologic care. She has contributed to numerous phase I-IV clinical studies of novel therapeutic regimens for the treatment of both inflammatory skin disorders and skin cancers.
Dr. Chen has publications in a variety of academic journals including the Journal of the American Academy of Dermatology, Archives of Dermatology, and Journal of Cutaneous Pathology.